Frontier Capital Management’s Guardant Health GH Stock Holding History

Frontier Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,003	Closed	-$431K	–	268
2022 Q3	$431K	Sell	8,003 -68,767	-90%	-$3.53M	0.01%	264
2022 Q2	$3.1M	Sell	76,770 -305,554	-80%	-$15.1M	0.04%	260
2022 Q1	$25.3M	Sell	382,324 -64,510	-14%	-$4.41M	0.23%	147
2021 Q4	$44.7M	Buy	446,834 +121,663	+37%	+$12.6M	0.35%	98
2021 Q3	$40.6M	Sell	325,171 -31,580	-9%	-$3.75M	0.32%	110
2021 Q2	$44.3M	Sell	356,751 -45,590	-11%	-$6.13M	0.32%	117
2021 Q1	$61.4M	Buy	402,341 +110,954	+38%	+$16.8M	0.46%	75
2020 Q4	$37.6M	Sell	291,387 -77,713	-21%	-$8.94M	0.28%	137
2020 Q3	$41.3M	Buy	369,100 +150,179	+69%	+$13.7M	0.36%	102
2020 Q2	$17.8M	Buy	218,921 +122,924	+128%	+$9.9M	0.16%	175
2020 Q1	$6.68M	Buy	95,997 +11,185	+13%	+$858K	0.08%	219
2019 Q4	$6.63M	Buy	84,812 +77,722	+1,096%	+$5.6M	0.05%	243
2019 Q3	$453K	Sell	7,090 -7,508	-51%	-$661K	﹤0.01%	286
2019 Q2	$1.26M	Buy	+14,598	New	+$1.11M	0.01%	282

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Frontier Capital Management's GH Position: Q4 2022 in Review

Frontier Capital Management sold out of Guardant Health (GH) in Q4 2022, closing a stake of 8,003 shares — an estimated $431K sold.

Frontier Capital Management first reported a position in GH in Q2 2019 and held it in 14 quarters. The position peaked at $61.4M in Q1 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

Frontier Capital Management reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
Frontier Capital Management sold 8,003 Guardant Health shares in Q4 2022, an estimated $431K.
Frontier Capital Management first reported a position in Guardant Health in Q2 2019 and held it in 14 quarters.
Frontier Capital Management's Guardant Health position peaked at $61.4M in Q1 2021.
290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Frontier Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.